Goldiam International (526729) Q1 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 23/24 earnings summary
20 Oct, 2026Executive summary
Q1 FY24 revenue declined amid US demand headwinds, while EBITDA and margins improved QoQ; lab-grown jewellery, online sales and Middle-East expansion advanced.
The Middle-East order win of ₹30 crore lifted the order book to ~₹110 crore at June 30, 2023.
Financial highlights
Consolidated revenue declined 14% YoY and 10% QoQ; consolidated profit before tax was ₹2,250.24 lakh and period profit was ₹1,730.05 lakh.
Consolidated total income was ₹12,118.40 lakh in Q1 FY24, versus ₹13,489.73 lakh in Q4 FY23 and ₹14,109.67 lakh in Q1 FY23.
Standalone revenue from operations was ₹5,831.91 lakh and period profit was ₹899.23 lakh.
Outlook and guidance
The ₹30 crore Middle-East order was scheduled for execution within six months; the order book stood at ~₹110 crore at June 30, 2023.
The festive season was expected to support demand recovery, while US discretionary spending had yet to fully rebound.
Lab-grown diamond jewellery was expected to increase its revenue contribution over time, supporting innovation and margin protection.
Latest events from Goldiam International
- Q2 revenue rose 50% as lab-grown jewellery gained share despite margin pressure.526729
Q2 23/24 - Q3 standalone profit rose while consolidated revenue fell versus the prior-year quarter.526729
Q3 23/24 - Lab-grown jewellery reached 49% of FY24 revenue as growth contrasted with lower Q4 audited profit.526729
Q4 23/24 - Q1 income rose as lab-grown jewellery reached 68.4% of export mix.526729
Q1 24/25 - H1 earnings grew as lab-grown mix expanded, while shipment delays and inventory weighed.526729
Q2 24/25 - Q3 consolidated profit rose as LGD exports expanded; a Rs 1 interim dividend was declared.526729
Q3 24/25 - FY25 earnings grew as lab-grown jewellery reached 82% of Q4 export revenue.526729
Q4 24/25 - Consolidated Q1 profit rose YoY, while standalone profit eased.526729
Q1 25/26 - Record FY26 earnings, 88% lab-grown export mix and a proposed 1-for-3 bonus.526729
Q4 25/26